⚠ For research purposes only — not for human consumption. Not evaluated by the FDA.
Tesamorelin
20mg
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog studied for body composition, fat reduction, and metabolic optimization. The 20mg formulation provides enhanced research dosing flexibility for dose-response studies and long-duration protocols.
How to Order
Preclinical Research Areas
- ●Growth hormone release stimulation (GHRH receptor)
- ●Visceral fat reduction research
- ●Metabolic optimization
- ●Body composition improvement
- ●IGF-1 pathway activation
Research protocols typically examine 1–2 mg daily subcutaneous administration for 8–12 weeks. Higher dose formulations may allow for reduced injection volume per unit of active compound. Follow your study protocol and consult published literature.
⚠ This information is from published scientific literature and is provided strictly for research reference. Not for human use. Follow all applicable laws and institutional protocols.
FDA-approved for HIV-associated lipodystrophy. Extensively studied for body composition and metabolic effects. 20mg formulation allows for flexible research dosing. Works via GHRH receptor — natural stimulation of the HGH axis.
- Every order includes a Certificate of Analysis (CoA) from a third-party lab
- Ships within 1–2 business days from Wichita, KS
- Domestic US shipping only
- Discreet packaging, no product names on external labels
- Questions? Email optilifewellness@polsia.app
Need reconstitution water?
Bacteriostatic water is required to reconstitute lyophilized peptides for research applications.
